Strong Support to Provide DAA Therapy to All Patients With HCV Strong Support to Provide DAA Therapy to All Patients With HCV
Direct-acting antiviral therapy significantly improves liver outcomes, nonliver outcomes, and long-term survival for patients with chronic hepatitis C virus, regardless of disease stage.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
More News: Antiviral Therapy | Drugs & Pharmacology | Gastroenterology | Hepatitis | Hepatitis C | Liver | Urology & Nephrology